Antidiabetics, Anthelmintics, Statins, and Beta-Blockers as Co-Adjuvant Drugs in Cancer Therapy

Antidiabetics, Anthelmintics, Statins, and Beta-Blockers as Co-Adjuvant Drugs in Cancer Therapy

Over the last years, repurposed agents have provided growing evidence of fast implementation in oncology treatment such as certain antimalarial, anthelmintic, antibiotics, anti-inflammatory, antihypertensive, antihyperlipidemic, antidiabetic agents. In this study, the four agents of choice were pres...

Full description

Bibliographic Details
Main Authors: Laurentia Gales, Leyla Forsea, Diana Mitrea, Irina Stefanica, Irina Stanculescu, Radu Mitrica, Mihai Georgescu, Oana Trifanescu, Rodica Anghel, Luiza Serbanescu
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Medicina
Subjects:
cancer therapy
metformin
mebendazole
atorvastatin
propranolol
beta-adrenergic receptors
Online Access:https://www.mdpi.com/1648-9144/58/9/1239

Internet

https://www.mdpi.com/1648-9144/58/9/1239

Similar Items